Related Experiment Video
Updated: Aug 11, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
[Therapeutic approach to tuberculosis brought in from Third World countries]
Tuberculosis (TB) incidence remains high in immigrants from developing nations, especially children. Preventive chemotherapy is crucial, but antibiotic resistance in these TB strains requires careful consideration for effective treatment.
Area of Science:
- Global Health
- Infectious Diseases
- Microbiology
Context:
- Tuberculosis (TB) incidence is disproportionately high in individuals migrating from developing countries, persisting for years post-migration.
- Children represent a particularly vulnerable demographic within these migrant populations, facing elevated TB risks.
- The long-term presence of TB in migrant communities necessitates ongoing public health interventions.
Purpose:
- To highlight the importance of surveillance and preventive chemotherapy for tuberculosis in migrant populations from developing countries.
- To underscore the challenge of antibiotic resistance in tubercle bacilli originating from these regions.
- To inform clinical practice regarding TB management in at-risk migrant groups.
Summary:
- Migrants from developing countries exhibit a sustained higher incidence of tuberculosis compared to their adoptive countries, with children being especially affected.
- Effective surveillance and preventive chemotherapy strategies are essential for controlling TB in these populations.
- A significant concern is the frequent resistance of tubercle bacilli from developing countries to multiple antibiotics, complicating treatment regimens.
Impact:
- Emphasizes the need for tailored public health strategies for TB control in migrant populations.
- Informs the development of diagnostic and treatment protocols that account for prevalent antibiotic resistance patterns.
- Contributes to reducing the global burden of tuberculosis, particularly in vulnerable, high-risk groups.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis